Globenewswire

Index
Globenewswire

Linnea SA Receives Swiss Narcotics License allowing for the Production and Exportation of High THC Active Pharmaceutical Ingredients

Globenewswire

Moleac Launches CognivAiD™, a Novel Targeted Product for Vascular Dementia

Globenewswire

Schneider Electric Calls for Greater Efforts to Accelerate the Energy Transition and Address the Energy Crisis: Decarbonization and Efficiency are Key

Globenewswire

FreedomPay to Unleash the Power of Pay at NRF 2023

Globenewswire

Flooid Announces Strategic Partnership with FreedomPay to Expand Global Reach

Globenewswire

Azerion to Simplify its Reporting Structure

Globenewswire

Zenas BioPharma Mengumumkan Pasien Pertama yang Diberi Dosis dalam Studi Klinis Fase 3 Obexelimab untuk Pengobatan Penyakit Terkait Imunoglobulin G4 (IgG4-RD)

Globenewswire

General Fusion’s Fusion Energy Demonstration Receives Consent at UKAEA’s Culham Campus

Globenewswire

Alarmed by Speed and Scale of Disruption, CEOs Embrace Sustainability to Build Long-Term Resilience, According to UN Global Compact and Accenture

Globenewswire

Nikkiso Clean Energy & Industrial Gases Group Mengumumkan Pengujian FAT Lapangan Perdana mereka di Fasilitas Kemaritiman mereka di Busan, Korea

Globenewswire

FURA Gems Menunjuk Mazars SA dan Memulai Proses Pendaftaran ke RJC

Globenewswire

NAT Global Campus Signs 3 More High Flyers to Meet the Demand for Quality Education Online

Globenewswire

Amlan International to Showcase Natural Mineral Technology at International Production and Processing Expo

Globenewswire

Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of up to $214 Million for Ebola Sudan and Marburg Vaccines

Globenewswire

L!X Modern Oral Nicotine Pouches Receive FDA Acceptance For Premarket Tobacco Product Application

Globenewswire

Euro Manganese Announces Offtake Term Sheet with Verkor

Globenewswire

Case IH and New Holland Agriculture win four ASABE 2023 Innovation Awards

Globenewswire

IIBA and HPRA Announce Strategic Partnership

Globenewswire

Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)

Globenewswire

LambdaTest Launches Test Analytics to Enable Better Decision Making

Globenewswire

The Yacht Club of Monaco Celebrates the 70th Anniversary with a Packed Programme of Festivities

Globenewswire

ChatGPT Imagines Self-Awareness

Globenewswire

Nikkiso Clean Energy & Industrial Gases Group Announces their First On-Site FAT Testing at their Marine Facility in Busan, Korea

Globenewswire

Early 2023 New Year Deals and Documentary Hero Recruiting From BLUETTI

Globenewswire

Veloce CPQ Acknowledged for Best Functionality in CPQ Vendor Assessment